<
Back to Previous Page
Article Summary: Bextra was prescribed to millions of Americans to treat the pain associated with arthritis, menstrual discomfort, and other ailments
Drug Recall On Bextra
Bextra was prescribed to millions of Americans to treat the pain associated with arthritis, menstrual discomfort, and other ailments. Now, in light of the Food and Drug Administration’s demand that Bextra’s manufacturer, Pfizer, pull the drug from the market, the firm anticipates an increase in individuals seeking to file suit to get compensation for their injuries.
On April 7, 2005 the FDA asked Pfizer, Inc. to withdraw the drug from the market because the overall risk versus benefit profile for the drug is unfavorable. Common risks associated with the drug include angina, heart attack, stroke, fatal skin reactions, and Stevens Johnson syndrome. Pfizer first acknowledged risks associated with Bextra in October of 2004. The American Heart Association soon after was presented with a report indicating patients using Bextra while recovering from heart surgery were 2.19 times more likely to suffer a stroke or heart attack than those taking placebos.
With the FDA’s request for the removal of the drug, there will undoubtedly be new awareness of the dangers associated with Bextra, and many users will want to know their rights and means of legal recourse. Weitz and Luxenberg has a dedicated team of lawyers and client relations specialists who have been reviewing Bextra claims for months, and who can answer questions and advise Bextra users of their best course of legal action.
If you or anyone you know has taken BEXTRA and has experienced the above symptoms or side effects, contact our BEXTRA lawyer and receive a free case evaluation.
|
